Showing results (1191-1200 of 1,230) with videos related to
Sort By:
Pageof 123
European Radiology|January 8, 2021
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control studyBei-Bei Xiao, Qiu-Yan Chen, Xue-Song Sun, et al.Cell Cycle (Georgetown, Tex.)|April 26, 2014
Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasisYing-Na Bao, Xue Cao, Dong-Hua Luo, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.BMC Cancer|December 18, 2015
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapyShan-Shan Guo, Lin-Quan Tang, Lu Zhang, et al.Oncotarget|April 23, 2016
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched studyShan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.Molecular Neurodegeneration|May 14, 2017
Anterograde monosynaptic transneuronal tracers derived from herpes simplex virus 1 strain H129Wen-Bo Zeng, Hai-Fei Jiang, Ya-Dong Gang, et al.Cell Research|November 11, 2022
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike proteinWei Pang, Ying Lu, Yan-Bo Zhao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.Cell Research|July 9, 2021
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signalingXiao-Ning Zhang, Kai-Di Yang, Cong Chen, et al.Pageof 123